Status:

COMPLETED

Effect of Paroxetine on COAT-Platelet Production in Normal Volunteers and Patients With Cardiovascular Disease

Lead Sponsor:

University of Oklahoma

Collaborating Sponsors:

GlaxoSmithKline

Conditions:

Coronary Artery Disease

Eligibility:

All Genders

18-65 years

Phase:

PHASE4

Brief Summary

COAT-platelets stands for collagen and thrombin stimulated platelets, which are two things in the body that make platelets stick together. These platelets may be important in the initiation of a heart...

Eligibility Criteria

Inclusion

  • normal volunteers (without heart disease)
  • patients with heart disease
  • between ages 18 \& 65

Exclusion

  • children less than 18 years
  • adults greater than 65 years
  • those who can not keep appointments
  • patients within 2 weeks of a coronary catheterization
  • patients within 6 months of unstable angina or myocardial infarction
  • individuals with allergies to paroxetine or similar medications
  • individuals having adverse events to paroxetine or similar medications
  • individuals with diagnosis of mania
  • individuals with a diagnosis of hypomania
  • individuals with a diagnosis of bipolar disorders
  • individuals with a diagnosis of depression
  • individuals with a diagnosis of panic disorders
  • individuals with a diagnosis of seizure disorders
  • individuals with a history of suicide attempts
  • individuals with a diagnosis of hyponatremia
  • individuals with active bleeding disorders
  • individuals with a diagnosis of narrow angle glaucoma
  • individuals with an estimated creatinine clearance of less that 30 ml/min
  • individuals taking potentially interacting medications

Key Trial Info

Start Date :

March 1 2004

Trial Type :

INTERVENTIONAL

End Date :

May 1 2006

Estimated Enrollment :

25 Patients enrolled

Trial Details

Trial ID

NCT00229528

Start Date

March 1 2004

End Date

May 1 2006

Last Update

September 22 2008

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

The University of Oklahoma Health Sciences Center

Oklahoma City, Oklahoma, United States, 73190